GENESIS PHARMA LIMITED

Company Registration Number:
11669127 (England and Wales)

Unaudited statutory accounts for the year ended 31 December 2022

(Dormant)

Period of accounts

Start date: 01 January 2022

End date: 31 December 2022

GENESIS PHARMA LIMITED

Contents of the Financial Statements

for the Period Ended 31 December 2022

Company Information - 3
Report of the Directors - 4
Profit and Loss Account - 5
Balance sheet - 6
Additional notes - 8

GENESIS PHARMA LIMITED

Company Information

for the Period Ended 31 December 2022




Director: Nilesh Mehta
Registered office: 84
Pembroke Road
London
GBR
W8 6NX
Company Registration Number: 11669127 (England and Wales)

GENESIS PHARMA LIMITED

Directors' Report Period Ended 31 December 2022

The directors present their report with the financial statements of the company for the period ended 31 December 2022

Directors

The directors shown below have held office during the whole of the period from 01 January 2022 to 31 December 2022
Nilesh Mehta

The company was dormant and did not trade in the period.

This report was approved by the board of directors on 29 September 2023
And Signed On Behalf Of The Board By:

Name: Nilesh Mehta
Status: Director

GENESIS PHARMA LIMITED

Profit and Loss Account

for the Period Ended 31 December 2022

The company was dormant and did not trade in the period. The company received no income and incurred no expenditure in the period and therefore did not make either a profit or loss.

GENESIS PHARMA LIMITED

Balance sheet

As at 31 December 2022


Notes

2022
£

2021
£
Fixed assets
Total fixed assets: - -
Current assets
Cash at bank and in hand: 100 100
Total current assets: 100 100
Net current assets (liabilities): 100 100
Total assets less current liabilities: 100 100
Total net assets (liabilities): 100 100

The notes form part of these financial statements

GENESIS PHARMA LIMITED

Balance sheet continued

As at 31 December 2022


Notes

2022
£

2021
£
Capital and reserves
Called up share capital: 100 100
Shareholders funds: 100 100

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

For the year ending 31 December 2022 the company was entitled to exemption under section 480 of the Companies Act 2006 relating to dormant companies.

This report was approved by the board of directors on 29 September 2023
And Signed On Behalf Of The Board By:

Name: Nilesh Mehta
Status: Director

The notes form part of these financial statements

GENESIS PHARMA LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2022

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

GENESIS PHARMA LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2022

  • 2. Employees


    2022

    2021
    Average number of employees during the period 0 0

GENESIS PHARMA LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2022

  • 3. Off balance sheet disclosure

    No